Ammonul: Phase II started

Hyperion began a double-blind, U.S. Phase II trial to compare 2.75 and 5.5 g/m 2 of intravenous Ammonul vs. placebo in hospitalized adults. Ammonul has Orphan Drug designation from FDA to treat grade ...